Carbon Dioxide (CO2) and Cognitive Impairment
Carbon Dioxide (CO2): A Pilot Study of a Hypothesized Mechanism to Explain Cognitive Impairment
1 other identifier
interventional
27
1 country
1
Brief Summary
The purpose of the study is to better understand the biological mechanisms of carbon dioxide (CO2)-induced cognitive impairments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Jul 2022
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2022
CompletedFirst Posted
Study publicly available on registry
March 23, 2022
CompletedStudy Start
First participant enrolled
July 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2025
CompletedResults Posted
Study results publicly available
March 16, 2026
CompletedMarch 16, 2026
February 1, 2026
2.7 years
January 24, 2022
February 19, 2026
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in PMN (Polymorphonuclear Leukocyte) Activation as Measured by Basal Oxygen Consumption (OCR)
Using blood samples collected 4 hours post-exposure, PMN activation was assessed by measurement of oxidative burst (oxygen consumption rate).
4 hours after each exposure
Change in PMN (Polymorphonuclear Leukocyte) Activation as Measured by Total Stimulated Oxygen Consumption.
Using blood samples collected 4 hours post-exposure, PMN activation was assessed by measurement of total stimulated oxygen consumption.
4 hours after each exposure
Change in PMN (Polymorphonuclear Leukocyte) Activation as Measured by Time to Peak (TTP) Oxygen Consumption
Using blood samples collected 4 hours post-exposure, PMN activation was assessed by measurement of time to peak (TTP) oxygen consumption.
4 hours after each exposure
Study Arms (2)
High CO2 Exposure first, then low CO2 exposure second.
EXPERIMENTALAt the first study visit the subject is exposed to 2500 ppm CO2 for 2.5 hours and at the second study visit the subject is exposed to 600 ppm CO2 for 2.5 hours.
Low CO2 Exposure first, then high CO2 exposure second.
SHAM COMPARATORAt the first study visit the subject is exposed to 600 ppm CO2 for 2.5 hours and at the second study visit the subject is exposed to 2500 ppm CO2 for 2.5 hours.
Interventions
2.5 hour exposure to 2500 ppm carbon dioxide
2.5 hour exposure to 600 ppm carbon dioxide
Eligibility Criteria
You may qualify if:
- History of COVID-19 vaccination
- Weigh at least 110 pounds
You may not qualify if:
- Colorblindness
- Inability to hear verbal instructions
- Cardiovascular disease, including a history of stroke
- Diabetes requiring the use of insulin
- Pregnancy
- Current asthma (an asthma attack within the past five years)
- Medications for or history of anxiety disorder diagnosis or panic attacks
- Medications which may affect cognition such as beta-blockers and CNS depressants
- Respiratory symptoms in the previous four weeks
- Use of sedating cold/allergy medications in the previous week
- Use of marijuana in the previous week
- Consumption of alcohol in the previous 24 hours
- History of head trauma or neurosurgery or neurological disorder
- Ferrous metal implanted in or on the body, electrical devices such as a pacemaker, nonremovable ferrous jewelry
- Surgical pins or plates above the neck
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rutgers - EOHSI
Piscataway, New Jersey, 08854, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Howard Kipen
- Organization
- Rutgers the State University of New Jersey
Study Officials
- PRINCIPAL INVESTIGATOR
Howard Kipen, MD
Professor
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 24, 2022
First Posted
March 23, 2022
Study Start
July 14, 2022
Primary Completion
March 20, 2025
Study Completion
March 20, 2025
Last Updated
March 16, 2026
Results First Posted
March 16, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available to other researchers.